Eurofins: H1 net profit up 46%
(CercleFinance.com) - Eurofins Scientific has reported a 46% increase in net profit to E220m for H1 2024 and an 18.
3% increase in adjusted EBITDA to E757m, representing a margin improvement of 2.2 points to 22.1%.
The bioanalytical services provider's sales rose by 6.5% to a record E3.42bn, supported by organic growth of 5.6% in its core business (i.e. excluding Covid-19 revenues).
Eurofins confirms its 2024 targets for adjusted EBITDA of between E1.525bn and E1.575bn, and sales of E7.075bn to E7.175bn, as well as its 2027 targets of an adjusted EBITDA margin of 24% and sales approaching E10bn.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
3% increase in adjusted EBITDA to E757m, representing a margin improvement of 2.2 points to 22.1%.
The bioanalytical services provider's sales rose by 6.5% to a record E3.42bn, supported by organic growth of 5.6% in its core business (i.e. excluding Covid-19 revenues).
Eurofins confirms its 2024 targets for adjusted EBITDA of between E1.525bn and E1.575bn, and sales of E7.075bn to E7.175bn, as well as its 2027 targets of an adjusted EBITDA margin of 24% and sales approaching E10bn.
Copyright (c) 2024 CercleFinance.com. All rights reserved.